Aurinia Pharmaceuticals Inc
AUPH
$16.51-1.31%
End of day · as of Oct 17, 2026, 9:16 PM ET
Mkt cap
$1.03B
EV/Sales
N/A
P/E ratio
7.21
Revenue (qtr ended 2026-06-30)
$83.22M
EPS (TTM)
$2.29
Gross Margin (qtr ended 2026-06-30)
92.12%
Profit Margin (qtr ended 2026-06-30)
44.96%
Beta
1.16
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $83.2M. Net income was $37.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. AUPH currently screens at market cap $1.03B and trailing P/E 7.2.
Use this AUPH research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AUPH income, balance, and cash tables.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company in the Healthcare sector.
Latest cached Aurinia Pharmaceuticals Inc (AUPH) revenue for Jun 30, 2026 was $83.2M. Net income was $37.4M. Statements: https://lician.com/financials/auph
Aurinia Pharmaceuticals Inc (AUPH) trailing P/E is 7.21 on the latest cached fundamentals snapshot.
Aurinia Pharmaceuticals Inc (AUPH) market capitalization is $1.03B on the latest cached snapshot.
Aurinia Pharmaceuticals Inc (AUPH) cached previous close $16.73; day range $16.51 – $16.81; volume 715,990. Session quote: https://lician.com/quote/auph
Aurinia Pharmaceuticals Inc (AUPH) latest cached earnings event is "AUPH earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings